12 Recruiting Studies Using Emapalumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Emapalumab
Severe Hepatitis Intervention With Emapalumab for Liver Disease
📍 Arthur M. Blank Children's Healthcare of Atlanta — Atlanta, Georgia
Hepatitis
View Study & Checklist ➔Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction
📍 University of California, Los Angeles — Los Angeles, California
Lung Transplant
View Study & Checklist ➔Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
📍 NYU Langone Health Perlmutter Cancer Center - Sunset Park — Brooklyn, New York
Multiple Myeloma
View Study & Checklist ➔A Study of Emapalumab for Pediatric Aplastic Anemia
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
Aplastic Anemia
View Study & Checklist ➔Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis
View Study & Checklist ➔Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
📍 City of Hope Medical Center — Duarte, California
Acute Myeloid Leukemia
View Study & Checklist ➔A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
📍 University of California, San Francisco — San Francisco, California
Primary Immune Regulatory Disorder
View Study & Checklist ➔Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
Hematopoietic Stem Cell Transplantation
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease
View Study & Checklist ➔Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
📍 University of Miami Hospital and Clinics — Miami, Florida
Dermatomyositis
View Study & Checklist ➔A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
📍 MD Anderson Cancer Center — Houston, Texas
Cytopenia
View Study & Checklist ➔Emapalumab Prevention of CAR-T Cell Associated Toxicities
📍 Massachusetts General Hospital — Boston, Massachusetts
Large B-cell Lymphoma
View Study & Checklist ➔